Published by Dordrecht, Springer., 2015
ISBN 10: 9401797315 ISBN 13: 9789401797313
Seller: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Germany
X, 271 p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Stamped. Sprache: Englisch.
Published by Springer Netherlands, 2015
ISBN 10: 9401797315 ISBN 13: 9789401797313
Seller: Buchpark, Trebbin, Germany
Condition: Sehr gut. Zustand: Sehr gut - Buchschnitt verkürzt - gepflegter, sauberer Zustand - Ausgabejahr 2015 | Seiten: 284 | Sprache: Englisch | Produktart: Bücher.
Published by Springer, 2015
ISBN 10: 9401797315 ISBN 13: 9789401797313
Seller: booksXpress, Bayonne, NJ, U.S.A.
Hardcover. Condition: new.
Published by Springer, 2015
ISBN 10: 9401797315 ISBN 13: 9789401797313
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Published by Springer, 2015
ISBN 10: 9401797315 ISBN 13: 9789401797313
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Condition: New.
Published by Springer, 2015
ISBN 10: 9401797315 ISBN 13: 9789401797313
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Published by Springer Netherlands Mrz 2015, 2015
ISBN 10: 9401797315 ISBN 13: 9789401797313
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This interdisciplinary volume collates research work on kinesins and cancer. Authors attempt to validate members of the kinesin superfamily as potential targets for drug development in cancer chemotherapy. The work begins by highlighting the importance of kinesins, summarising current knowledge and how they are shown to be crucial for mitosis. Chapters go on to explore how this family of proteins are emerging as a novel target for chemotherapeutic intervention and drug development.Readers will learn how kinesins travel along microtubules to fulfill their many roles in intracellular transport or cell division. Several compounds that inhibit two mitotic kinesins (called Eg5 and CENP-E) have entered Phase I and II clinical trials and are explored in these chapters. Additional mitotic kinesins are currently being validated as drug targets, raising the possibility that the repertoire of kinesin-based drug targets may expand in the future.The book is suitable as a reference standard for the field of kinesins and cancer. It will interest those in academia and pharmaceutical companies, and anyone with an interest in the medical relevance of these proteins, which cutting edge methodologies are now enabling us to understand in astonishing detail. 284 pp. Englisch.
Published by Springer Netherlands Okt 2016, 2016
ISBN 10: 9402403655 ISBN 13: 9789402403657
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This interdisciplinary volume collates research work on kinesins and cancer. Authors attempt to validate members of the kinesin superfamily as potential targets for drug development in cancer chemotherapy. The work begins by highlighting the importance of kinesins, summarising current knowledge and how they are shown to be crucial for mitosis. Chapters go on to explore how this family of proteins are emerging as a novel target for chemotherapeutic intervention and drug development.Readers will learn how kinesins travel along microtubules to fulfill their many roles in intracellular transport or cell division. Several compounds that inhibit two mitotic kinesins (called Eg5 and CENP-E) have entered Phase I and II clinical trials and are explored in these chapters. Additional mitotic kinesins are currently being validated as drug targets, raising the possibility that the repertoire of kinesin-based drug targets may expand in the future.The book is suitable as a reference standard for the field of kinesins and cancer. It will interest those in academia and pharmaceutical companies, and anyone with an interest in the medical relevance of these proteins, which cutting edge methodologies are now enabling us to understand in astonishing detail. 284 pp. Englisch.
Published by Springer, 2015
ISBN 10: 9401797315 ISBN 13: 9789401797313
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Condition: New.
Published by Springer Netherlands, 2015
ISBN 10: 9401797315 ISBN 13: 9789401797313
Seller: moluna, Greven, Germany
Gebunden. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Covers the entire, interdisciplinary field of kinesins and cancer through expert contributionsOffers a timely reference standard on the relevance of kinesins to cancer treatmentContributes to potential initial validation of mitotic ki.
Published by Springer Netherlands, 2016
ISBN 10: 9402403655 ISBN 13: 9789402403657
Seller: moluna, Greven, Germany
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Covers the entire, interdisciplinary field of kinesins and cancer through expert contributionsOffers a timely reference standard on the relevance of kinesins to cancer treatmentContributes to potential initial validation of mitotic ki.
Published by Springer, 2015
ISBN 10: 9401797315 ISBN 13: 9789401797313
Seller: Revaluation Books, Exeter, United Kingdom
Hardcover. Condition: Brand New. 1st edition. 271 pages. 9.25x6.25x0.75 inches. In Stock.
Published by Springer Netherlands, 2016
ISBN 10: 9402403655 ISBN 13: 9789402403657
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This interdisciplinary volume collates research work on kinesins and cancer. Authors attempt to validate members of the kinesin superfamily as potential targets for drug development in cancer chemotherapy. The work begins by highlighting the importance of kinesins, summarising current knowledge and how they are shown to be crucial for mitosis. Chapters go on to explore how this family of proteins are emerging as a novel target for chemotherapeutic intervention and drug development.Readers will learn how kinesins travel along microtubules to fulfill their many roles in intracellular transport or cell division. Several compounds that inhibit two mitotic kinesins (called Eg5 and CENP-E) have entered Phase I and II clinical trials and are explored in these chapters. Additional mitotic kinesins are currently being validated as drug targets, raising the possibility that the repertoire of kinesin-based drug targets may expand in the future.The book is suitable as a reference standard for the field of kinesins and cancer. It will interest those in academia and pharmaceutical companies, and anyone with an interest in the medical relevance of these proteins, which cutting edge methodologies are now enabling us to understand in astonishing detail.
Published by Springer Netherlands, 2015
ISBN 10: 9401797315 ISBN 13: 9789401797313
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This interdisciplinary volume collates research work on kinesins and cancer. Authors attempt to validate members of the kinesin superfamily as potential targets for drug development in cancer chemotherapy. The work begins by highlighting the importance of kinesins, summarising current knowledge and how they are shown to be crucial for mitosis. Chapters go on to explore how this family of proteins are emerging as a novel target for chemotherapeutic intervention and drug development.Readers will learn how kinesins travel along microtubules to fulfill their many roles in intracellular transport or cell division. Several compounds that inhibit two mitotic kinesins (called Eg5 and CENP-E) have entered Phase I and II clinical trials and are explored in these chapters. Additional mitotic kinesins are currently being validated as drug targets, raising the possibility that the repertoire of kinesin-based drug targets may expand in the future.The book is suitable as a reference standard for the field of kinesins and cancer. It will interest those in academia and pharmaceutical companies, and anyone with an interest in the medical relevance of these proteins, which cutting edge methodologies are now enabling us to understand in astonishing detail.
Published by Springer, 2015
ISBN 10: 9401797315 ISBN 13: 9789401797313
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Condition: As New. Unread book in perfect condition.
Published by Springer, 2015
ISBN 10: 9401797315 ISBN 13: 9789401797313
Seller: Mispah books, Redhill, SURRE, United Kingdom
Hardcover. Condition: Like New. Like New. book.
Published by Springer, 2015
ISBN 10: 9401797315 ISBN 13: 9789401797313
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition.
Published by Springer, 2016
ISBN 10: 9402403655 ISBN 13: 9789402403657
Seller: Mispah books, Redhill, SURRE, United Kingdom
Paperback. Condition: Like New. Like New. book.
Published by Springer, 2016
ISBN 10: 9402403655 ISBN 13: 9789402403657
Seller: Revaluation Books, Exeter, United Kingdom
Paperback. Condition: Brand New. reprint edition. 281 pages. 9.25x6.10x0.67 inches. In Stock.